Overview

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Status:
Not yet recruiting
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether clinical response (the amount a tumor shrinks based on imaging or tumor measurements obtained by physical exam) predicts pathologic response (the amount of tumor remaining when surgery is performed) in patients with breast cancer who are receiving chemotherapy prior to surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Baylor Breast Care Center
Treatments:
Carboplatin
Cyclophosphamide
Doxorubicin
Paclitaxel
Pertuzumab
Trastuzumab